Terms: = Sarcomas AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
41 results:
1. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
[TBL] [Abstract] [Full Text] [Related]
2. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
3. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
Lim HJ; Zhuang L; Fitzgerald RC
J Exp Clin Cancer Res; 2023 Mar; 42(1):57. PubMed ID: 36869400
[TBL] [Abstract] [Full Text] [Related]
4. Relaxin inhibits
Xu J; Wan S; Chen W; Zhang Y; Ji Z
Acta Pharm; 2022 Dec; 72(4):575-585. PubMed ID: 36651368
[No Abstract] [Full Text] [Related]
5. Discovery and functional characterization of the oncogenicity and targetability of a novel
Jain P; Iyer S; Straka J; Surrey LF; Pogoriler J; Han H; Smith T; Busch C; Fox E; Li M; Waanders AJ; Resnick A; Davare MA
Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307212
[TBL] [Abstract] [Full Text] [Related]
6. Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review.
Hayashi H; Makiyama A; Okumura N; Yasufuku I; Saigo C; Takeuchi T; Miyazaki T; Tanaka Y; Matsuhashi N; Murase K; Takahashi T; Futamura M; Yoshida K
BMC Gastroenterol; 2022 Jul; 22(1):360. PubMed ID: 35902814
[TBL] [Abstract] [Full Text] [Related]
7. Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating Notch signaling pathway.
Yang J; Hu Y; Wang L; Sun X; Yu L; Guo W
Bioengineered; 2021 Dec; 12(2):11007-11017. PubMed ID: 34781817
[TBL] [Abstract] [Full Text] [Related]
8. Effect of the notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma.
Zhang K; Wu S; Wu H; Liu L; Zhou J
Aging (Albany NY); 2021 Sep; 13(17):21090-21101. PubMed ID: 34495871
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
[TBL] [Abstract] [Full Text] [Related]
10. CT Attenuation and Cross-sectional-area Index of the Pectoralis Are Associated With Prognosis in Sarcoma Patients.
Jo S; Sebro R
Anticancer Res; 2021 Apr; 41(4):1927-1935. PubMed ID: 33813398
[TBL] [Abstract] [Full Text] [Related]
11. Tideglusib suppresses stem-cell-like features and progression of osteosarcoma by inhibiting GSK-3β/notch1 signaling.
Wei D; Zhu X; Li S; Liu G; Wang Y; Wang W; Zhang Q; Jiang S
Biochem Biophys Res Commun; 2021 May; 554():206-213. PubMed ID: 33813076
[TBL] [Abstract] [Full Text] [Related]
12. MYC and notch1-positive postradiation cutaneous angiosarcoma of the breast.
Sheu TG; Hunt KK; Middleton LP
Breast J; 2021 Mar; 27(3):264-267. PubMed ID: 33527629
[TBL] [Abstract] [Full Text] [Related]
13. Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20.
Gao Y; Bai L; Shang G
Aging (Albany NY); 2020 Dec; 13(2):2668-2680. PubMed ID: 33411691
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract] [Full Text] [Related]
15. The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
Yu L; Xia K; Gao T; Chen J; Zhang Z; Sun X; Simões BM; Eyre R; Fan Z; Guo W; Clarke RB
Mol Cancer Res; 2019 Dec; 17(12):2383-2394. PubMed ID: 31570655
[TBL] [Abstract] [Full Text] [Related]
16. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.
Alegre F; Ormonde AR; Snider KM; Woolard K; Yu AM; Wittenburg LA
PLoS One; 2018; 13(12):e0209941. PubMed ID: 30596759
[TBL] [Abstract] [Full Text] [Related]
17. MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting notch1.
Liu Q; Song Y; Duan X; Chang Y; Guo J
Biomed Res Int; 2018; 2018():9870693. PubMed ID: 29984257
[TBL] [Abstract] [Full Text] [Related]
18. Targetable Alterations in Adult Patients With Soft-Tissue sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
[TBL] [Abstract] [Full Text] [Related]
20. Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?
Caponigro F; Ionna F; Scarpati GDV; Longo F; Addeo R; Manzo R; Muto P; Pisconti S; Leopaldi L; Perri F
Anticancer Agents Med Chem; 2018; 18(9):1220-1227. PubMed ID: 29637868
[TBL] [Abstract] [Full Text] [Related]
[Next]
